As of Jan. 1, 2024, IGeneX will now not provide the Western blot take a look at for Lyme disease. Will probably be changed by the ImmunBlot.
The corporate says the ImmunoBlot differs from the Western blot in two key methods.
“First, it seems for a number of pathogens, as an alternative of 1 with the Western blot. And second, it makes use of recombinant proteins as an alternative of proteins from pure sources, resulting in a extra particular take a look at.”
The web site goes on to say: “Frequent Lyme two-tier testing has a sensitivity of simply above 50% as a result of it detects just one Borrelia species, B. burgdorferi B31. The IGeneX ImmunoBlot detects antibodies to 9 totally different species of Borrelia: B. burgdorferi B31, B. burgdorferi 297, B. californiensis, B. mayonii, B. afzelii, B. garinii, B. spielmanii, B. bissettii, and B. valaisianaa.”
The corporate gives Immunoblots for 4 illnesses: Lyme, tick-borne relapsing fever, Bartonella, and Babesia.
